Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Deciphera Pharmaceuticals...

    NASDAQ: DCPH · Real-Time Price · USD
    25.59
    0.02 (0.08%)
    At close: Jun 10, 2024, 10:00 PM

    Deciphera Pharmaceuticals Statistics

    Share Statistics

    Deciphera Pharmaceuticals has 86.48M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 86.48M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 46.43M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,305

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 3.17M, so 3.67% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.17M

    Short % of Shares Out

    n/a
    		 3.67%

    Short % of Float

    n/a
    		 5.12%

    Short Ratio (days to cover)

    n/a
    		 2.79

    Valuation Ratios

    The PE ratio is -7.04 and the forward PE ratio is null. Deciphera Pharmaceuticals's PEG ratio is 2.09.

    PE Ratio

    n/a
    		 -7.04

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 8.4

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.91

    P/FCF Ratio

    n/a
    		 -9.3

    PEG Ratio

    n/a
    		 2.09
    Financial Ratio History

    Enterprise Valuation

    Deciphera Pharmaceuticals has an Enterprise Value (EV) of 1.31B.

    EV / Sales

    n/a
    		 8.05

    EV / EBITDA

    n/a
    		 -6.29

    EV / EBIT

    n/a
    		 -8.96

    EV / FCF

    n/a
    		 -8.91

    Financial Position

    The company has a current ratio of 3.8, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 3.8

    Quick Ratio

    n/a
    		 3.59

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.12

    Debt / FCF

    n/a
    		 -0.18

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is -55.55% and Return on Invested Capital is -56.11%.

    Return on Equity

    n/a
    		 -55.55%

    Return on Assets

    n/a
    		 -41.16%

    Return on Invested Capital

    n/a
    		 -56.11%

    Revenue Per Employee

    n/a
    		 $460,157.75

    Profits Per Employee

    n/a
    		 $-549,132.39

    Employee Count

    n/a
    		 355

    Asset Turnover

    n/a
    		 0.34

    Inventory Turnover

    n/a
    		 0.18

    Taxes

    Income Tax

    n/a
    		 431K

    Effective Tax Rate

    n/a
    		 -0.22%

    Stock Price Statistics

    The stock price has increased by 75.03% in the last 52 weeks. The beta is 0.18, so Deciphera Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.18

    52-Week Price Change

    n/a
    		 75.03%

    50-Day Moving Average

    n/a
    		 21.46

    200-Day Moving Average

    n/a
    		 15.86

    Relative Strength Index (RSI)

    n/a
    		 85.58

    Average Volume (20 Days)

    n/a
    		 1,855,995

    Income Statement

    In the last 12 months, Deciphera Pharmaceuticals had revenue of 163.36M and earned -194.94M in profits. Earnings per share was -2.29.

    Revenue

    n/a
    		 163.36M

    Gross Profit

    n/a
    		 159.62M

    Operating Income

    n/a
    		 -210.96M

    Net Income

    n/a
    		 -194.94M

    EBITDA

    n/a
    		 -208.86M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -2.29
    Full Income Statement

    Balance Sheet

    The company has 83.51M in cash and 25.88M in debt, giving a net cash position of 57.63M.

    Cash & Cash Equivalents

    n/a
    		 83.51M

    Total Debt

    n/a
    		 25.88M

    Net Cash

    n/a
    		 57.63M

    Retained Earnings

    n/a
    		 -1.43B

    Total Assets

    n/a
    		 420.93M

    Working Capital

    n/a
    		 266.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -146.7M and capital expenditures -778K, giving a free cash flow of -147.47M.

    Operating Cash Flow

    n/a
    		 -146.7M

    Capital Expenditures

    n/a
    		 -778K

    Free Cash Flow

    n/a
    		 -147.47M

    FCF Per Share

    n/a
    		 -1.73
    Full Cash Flow Statement

    Margins

    Gross margin is 97.72%, with operating and profit margins of -129.14% and -119.34%.

    Gross Margin

    n/a
    		 97.72%

    Operating Margin

    n/a
    		 -129.14%

    Pretax Margin

    n/a
    		 -119.07%

    Profit Margin

    n/a
    		 -119.34%

    EBITDA Margin

    n/a
    		 -127.85%

    EBIT Margin

    n/a
    		 -129.14%

    FCF Margin

    n/a
    		 -90.28%

    Dividends & Yields

    DCPH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -14.21%

    FCF Yield

    n/a
    		 -10.75%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DCPH.

    Price Target

    n/a
    		 $25.6

    Price Target Difference

    n/a
    		 0%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.31

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist